Search for Clinical Trial Results
Epistaxis - 27 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia Condition:
Date: 2011-11-28 Interventions: Drug: Thalidomide Eligible patients will receive thalidomi |
Withdrawn |
Study Name: Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) Condition:
Interventions: Drug: Ranibizumab Patients will be treated with a total of 4 applications of ranibizumab in a fine mist |
Recruiting |
Study Name: Intranasal Bevacizumab for HHT-Related Epistaxis Condition:
|
Completed |
Study Name: Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Condition:
|
Recruiting |
Study Name: The Effect of Intranasal Vasoconstrictor Medications on Hemodynamic Parameters: A Randomized Double-blind, Placebo-controlled Trial. Condition:
Date: 2014-11-05 Interventions:
|
RECRUITING |
Study Name: Nasal Compression Device Study for Epistaxis Condition: Epistaxis Nosebleed Date: 2024-05-19 Interventions: Participants assigned to the NasaClip arm will not receive routine care as the objective of this study is to compare the NasaClip device to routine di |
RECRUITING |
Study Name: Cauterization of the Anterior Ethmoidal Artery by Transconjunctival Approach Condition: Epistaxis, Anterior Ethmoid Artery Date: 2024-05-19 |